Reference pricing drug groups remarkably scaled down.

The reference pricing system seems to be remarkably reduced in its therapeutic groups on the contrary to the earlier projection.


In the explanatory meeting with relevant organizations on June 25 the MOHW made it clear that the reference pricing system be applicable to 11 therapeutic groups including the muscle relaxants, the anti-diabetics, the analgesic and anti-inflammatory drugs, the an...